title: Regulation of hepatocyte adenylate cyclase by amylin and CGRP: a single receptor displaying apparent negative cooperatively towards CGRP and simple saturation kinetics for amylin, a requirement for phosphodiesterase inhibition to observe elevated hepatocyte cyclic AMP levels and the phosphorylation of Gi-2.
abstract: Challenge of intact hepatocytes with amylin only succeeded in elevating intracellular cyclic AMP levels and activating phosphorylase in the presence of the cAMP phosphodiesterase inhibitor IBMX. Both amylin and CGRP similarly activated adenylate cyclase, around 5-fold, although approximately 400-fold higher levels of amylin were required to elicit half maximal activation. Amylin activated adenylate cyclase though apparently simple Michaelien kinetics whereas CGRP elicited activation by kinetics indicative of apparent negative co-operativity. Use of the antagonist CGPP(8-37) showed that both CGRP and amylin activated hepatocyte adenylate cyclase through a common receptor by a mnemonical mechanism where it was proposed that the receptor co-existed in interconvertible high and low affinity states for CGRP. It is suggested that this model may serve as a paradigm for G-protein linked receptors in general. Amylin failed to both stimulate inositol phospholipid metabolism in hepatocytes and to elicit the desensitization of glucagon-stimulated adenylate cyclase. Amylin did, however, elicit the phosphorylation of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes and prevented the action of insulin in reducing the level of phosphorylation of this G-protein.
authors.affiliation: Department of Biochemistry, University of Glasgow, Scotland.
authors.forename: M D
authors.initials: MD
authors.lastname: Houslay
authors.forename: N J
authors.initials: NJ
authors.lastname: Morris
authors.forename: A
authors.initials: A
authors.lastname: Savage
authors.forename: A
authors.initials: A
authors.lastname: Marker
authors.forename: M
authors.initials: M
authors.lastname: Bushfield
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism*; D000682:Amyloid / Q000378:metabolism* / Q000494:pharmacology*; D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology*; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000378:metabolism*; D058228:Islet Amyloid Polypeptide; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008954:Models, Biological; D010766:Phosphorylation; D051381:Rats; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000502:physiology*; D058287:Receptors, Islet Amyloid Polypeptide; D018000:Receptors, Peptide / Q000502:physiology*
chemical_list: D000682:Amyloid; D058228:Islet Amyloid Polypeptide; D018015:Receptors, Calcitonin Gene-Related Peptide; D058287:Receptors, Islet Amyloid Polypeptide; D018000:Receptors, Peptide; D000242:Cyclic AMP; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D015740:Calcitonin Gene-Related Peptide